Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1995 Aug;222(2):155–162. doi: 10.1097/00000658-199508000-00007

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

F M Kong 1, M S Anscher 1, T Murase 1, B D Abbott 1, J D Iglehart 1, R L Jirtle 1
PMCID: PMC1234773  PMID: 7543740

Abstract

OBJECTIVE: The authors determined whether untreated breast cancer patients have elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1). SUMMARY BACKGROUND DATA: Increased plasma TGF-beta 1 levels recently were found after chemotherapy in patients with advanced breast cancer. However, it currently is unknown whether this elevation in plasma TGF-beta 1 is caused by chemotherapy-induced normal tissue damage or whether it results from the presence of the tumor. METHODS: An enzyme-linked immunosorbent assay was used to measure plasma TGF-beta 1 levels in 26 newly diagnosed breast cancer patients before and after definitive surgery. Patients were grouped by postoperative tumor status: 1) negative lymph nodes (group 1); 2) positive lymph nodes (group 2); and 3) overt residual disease (group 3). The site of TGF-beta 1 production in the tumors was localized by immunohistochemistry and in situ hybridization. RESULTS: Plasma TGF-beta 1 levels were elevated preoperatively in 81% of the patients; TGF-beta 2 and TGF-beta 3 were undetectable. The preoperative TGF-beta 1 levels in the three patient groups were similar; however, the postoperative plasma TGF-beta 1 levels differed by disease status. The mean plasma TGF-beta 1 level in group 1 (n = 12) normalized after surgery (19.3 +/- 3.2 vs. 5.5 +/- 1.0 ng/mL, p < 0.001). In contrast, the mean plasma TGF-beta 1 levels remained above normal in both group 2 (n = 9) and group 3 (n = 5) after surgery. Transforming growth factor-beta 1 expression was found to be preferentially increased in the tumor stroma. CONCLUSIONS: Breast tumors result in increased plasma TGF-beta 1 levels in 81% of patients. After surgical removal of the primary tumor, the plasma TGF-beta 1 level normalizes in the majority of patients; persistently elevated levels correlate with the presence of lymph node metastases or overt residual tumor. These findings suggest that the usefulness of TGF-beta 1 as a potential plasma marker for breast tumors deserves further study.

Full text

PDF
155

Images in this article

160Figure 4.
on p.160
161Figure 5.
on p.161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott B. D., Harris M. W., Birnbaum L. S. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology. 1992 Jan;45(1):35–53. doi: 10.1002/tera.1420450104. [DOI] [PubMed] [Google Scholar]
  2. Anscher M. S., Murase T., Prescott D. M., Marks L. B., Reisenbichler H., Bentel G. C., Spencer D., Sherouse G., Jirtle R. L. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):671–676. doi: 10.1016/0360-3016(92)90954-g. [DOI] [PubMed] [Google Scholar]
  3. Anscher M. S., Peters W. P., Reisenbichler H., Petros W. P., Jirtle R. L. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med. 1993 Jun 3;328(22):1592–1598. doi: 10.1056/NEJM199306033282203. [DOI] [PubMed] [Google Scholar]
  4. Butta A., MacLennan K., Flanders K. C., Sacks N. P., Smith I., McKinna A., Dowsett M., Wakefield L. M., Sporn M. B., Baum M. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 1992 Aug 1;52(15):4261–4264. [PubMed] [Google Scholar]
  5. Clarke R., Dickson R. B., Lippman M. E. Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol. 1992 Jan;12(1):1–23. doi: 10.1016/1040-8428(92)90062-u. [DOI] [PubMed] [Google Scholar]
  6. Cullen K. J., Smith H. S., Hill S., Rosen N., Lippman M. E. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res. 1991 Sep 15;51(18):4978–4985. [PubMed] [Google Scholar]
  7. Dalal B. I., Keown P. A., Greenberg A. H. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol. 1993 Aug;143(2):381–389. [PMC free article] [PubMed] [Google Scholar]
  8. Dasch J. R., Pace D. R., Waegell W., Inenaga D., Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol. 1989 Mar 1;142(5):1536–1541. [PubMed] [Google Scholar]
  9. Delvenne C. G., Winkler-Gol R. A., Piccart M. J., Hustin J., Michaux D., Leclercq G., Nogaret J. M., Autier P. Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers. Eur J Cancer. 1992;28(2-3):700–705. doi: 10.1016/s0959-8049(05)80130-3. [DOI] [PubMed] [Google Scholar]
  10. Dickson R. B. Stimulatory and inhibitory growth factors and breast cancer. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):795–803. doi: 10.1016/0960-0760(90)90422-h. [DOI] [PubMed] [Google Scholar]
  11. Dublin E. A., Barnes D. M., Wang D. Y., King R. J., Levison D. A. TGF alpha and TGF beta expression in mammary carcinoma. J Pathol. 1993 May;170(1):15–22. doi: 10.1002/path.1711700104. [DOI] [PubMed] [Google Scholar]
  12. Ellingsworth L. R., Brennan J. E., Fok K., Rosen D. M., Bentz H., Piez K. A., Seyedin S. M. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells. J Biol Chem. 1986 Sep 15;261(26):12362–12367. [PubMed] [Google Scholar]
  13. Flanders K. C., Thompson N. L., Cissel D. S., Van Obberghen-Schilling E., Baker C. C., Kass M. E., Ellingsworth L. R., Roberts A. B., Sporn M. B. Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol. 1989 Feb;108(2):653–660. doi: 10.1083/jcb.108.2.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gorsch S. M., Memoli V. A., Stukel T. A., Gold L. I., Arrick B. A. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res. 1992 Dec 15;52(24):6949–6952. [PubMed] [Google Scholar]
  15. Jeng M. H., Jordan V. C. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Mol Endocrinol. 1991 Aug;5(8):1120–1128. doi: 10.1210/mend-5-8-1120. [DOI] [PubMed] [Google Scholar]
  16. Jirtle R. L., Haag J. D., Ariazi E. A., Gould M. N. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res. 1993 Sep 1;53(17):3849–3852. [PubMed] [Google Scholar]
  17. Jirtle R. L., Hankins G. R., Reisenbichler H., Boyer I. J. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis. 1994 Aug;15(8):1473–1478. doi: 10.1093/carcin/15.8.1473. [DOI] [PubMed] [Google Scholar]
  18. Kehrl J. H., Taylor A. S., Delsing G. A., Roberts A. B., Sporn M. B., Fauci A. S. Further studies of the role of transforming growth factor-beta in human B cell function. J Immunol. 1989 Sep 15;143(6):1868–1874. [PubMed] [Google Scholar]
  19. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986 May 1;163(5):1037–1050. doi: 10.1084/jem.163.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Knabbe C., Lippman M. E., Wakefield L. M., Flanders K. C., Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987 Feb 13;48(3):417–428. doi: 10.1016/0092-8674(87)90193-0. [DOI] [PubMed] [Google Scholar]
  21. Letterio J. J., Geiser A. G., Kulkarni A. B., Roche N. S., Sporn M. B., Roberts A. B. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 1994 Jun 24;264(5167):1936–1938. doi: 10.1126/science.8009224. [DOI] [PubMed] [Google Scholar]
  22. Lucas C., Wallick S., Fendly B. M., Figari I., Palladino M. A. TGF-beta: a possible autocrine immune regulator. Ciba Found Symp. 1991;157:98–114. doi: 10.1002/9780470514061.ch7. [DOI] [PubMed] [Google Scholar]
  23. Lønning P. E., Hall K., Aakvaag A., Lien E. A. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res. 1992 Sep 1;52(17):4719–4723. [PubMed] [Google Scholar]
  24. Macias A., Perez R., Hägerström T., Skoog L. Identification of transforming growth factor alpha in human primary breast carcinomas. Anticancer Res. 1987 Nov-Dec;7(6):1271–1275. [PubMed] [Google Scholar]
  25. Matsui Y., Halter S. A., Holt J. T., Hogan B. L., Coffey R. J. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell. 1990 Jun 15;61(6):1147–1155. doi: 10.1016/0092-8674(90)90077-r. [DOI] [PubMed] [Google Scholar]
  26. Oda K., Hori S., Itoh H., Osamura R. Y., Tokuda Y., Kubota M., Tajima T. Immunohistochemical study of transforming growth factor beta, fibronectin, and fibronectin receptor in invasive mammary carcinomas. Acta Pathol Jpn. 1992 Sep;42(9):645–650. doi: 10.1111/j.1440-1827.1992.tb03045.x. [DOI] [PubMed] [Google Scholar]
  27. Roberts A. B., Lamb L. C., Newton D. L., Sporn M. B., De Larco J. E., Todaro G. J. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3494–3498. doi: 10.1073/pnas.77.6.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rosen N., Yee D., Lippman M. E., Paik S., Cullen K. J. Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat. 1991 May;18 (Suppl 1):S55–S62. doi: 10.1007/BF02633529. [DOI] [PubMed] [Google Scholar]
  29. Saito S., Yoshida M., Ichijo M., Ishizaka S., Tsujii T. Transforming growth factor-beta (TGF-beta) in human milk. Clin Exp Immunol. 1993 Oct;94(1):220–224. doi: 10.1111/j.1365-2249.1993.tb06004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sandgren E. P., Luetteke N. C., Palmiter R. D., Brinster R. L., Lee D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990 Jun 15;61(6):1121–1135. doi: 10.1016/0092-8674(90)90075-p. [DOI] [PubMed] [Google Scholar]
  31. Sasaki M., Nishio M., Sasaki T., Enami J. Identification of mouse mammary fibroblast-derived mammary growth factor as hepatocyte growth factor. Biochem Biophys Res Commun. 1994 Mar 15;199(2):772–779. doi: 10.1006/bbrc.1994.1296. [DOI] [PubMed] [Google Scholar]
  32. Shirai Y., Kawata S., Tamura S., Ito N., Tsushima H., Takaishi K., Kiso S., Matsuzawa Y. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer. 1994 May 1;73(9):2275–2279. doi: 10.1002/1097-0142(19940501)73:9<2275::aid-cncr2820730907>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  33. Tsarfaty I., Resau J. H., Rulong S., Keydar I., Faletto D. L., Vande Woude G. F. The met proto-oncogene receptor and lumen formation. Science. 1992 Aug 28;257(5074):1258–1261. doi: 10.1126/science.1387731. [DOI] [PubMed] [Google Scholar]
  34. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988 Jul 21;334(6179):260–262. doi: 10.1038/334260a0. [DOI] [PubMed] [Google Scholar]
  35. Walker R. A., Dearing S. J. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer. 1992;28(2-3):641–644. doi: 10.1016/s0959-8049(05)80116-9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES